Saltar hacia el contenido principal

Referencias de la leucemia linfocítica aguda

En esta página

Advani AS, McDonough S, Coutre S, et al. SWOG S0910: a phase 2 trial of clofarabine/cytarabine/epratuzumab for relapsed/refractory acute lymphocytic leukaemia. Br J Haematol. 2014 May;165(4):504-9. Epub 2014 Mar 3.

American Cancer Society. Cancer Facts & Figures 2016. Atlanta, Ga: American Cancer Society; 2016.

American Cancer Society. Cancer Facts & Figures 2017. Atlanta, Ga: American Cancer Society; 2017.

Faderl S, O’Brien S, Pui CH, et al. Adult acute lymphoblastic leukemia: concepts and strategies. Cancer. 2010;116:1165-1176.

Hoelzer D, Gokbuget N. Acute lymphocytic leukemia in adults. In: Abeloff MD, Armitage JO, Niederhuber JE. Kastan MB, McKenna WG, eds. Abeloff’s Clinical Oncology. 4th ed. Philadelphia, Pa: Elsevier; 2008:2191-2213.

Howlader N, Noone AM, Krapcho M, et al (eds). SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations), National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2009_pops09/, based on November 2011 SEER data submission, posted to the SEER Web site, April 2012.

Kantarjian H, Thomas D, Jorgensen J, et al. Results of inotuzumab ozogamicin, a CD22 monoclonal antibody, in refractory and relapsed acute lymphocytic leukemia. Cancer. 2013 Aug 1;119(15):2728-36. Epub 2013 Apr 30.

Kebriaei P, Champlin R, de Lima M, Estey E. Management of acute leukemias. In: DeVita VT, Lawrence TS, Rosenberg SA, eds. DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology. 9th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2011:1928-1954.

Marks DI. Treating the “older” adult with acute lymphoblastic anemia. In: Hematology 2010. American Society of Hematology Education Program Book. 2010:13-20. Accessed at http://asheducationbook.hematologylibrary.org/cgi/content/full/2010/1/13 on October 24, 2011.

National Cancer Institute. Physician Data Query (PDQ). Adult Acute Lymphoblastic Leukemia Treatment. 2/13/2013. Accessed at www.cancer.gov/cancertopics/pdq/treatment/adultALL/healthprofessional on March 15, 2013.

National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Acute Lymphoblastic Leukemia. V.2.2012. Accessed at: www.nccn.org on 2/7/2013.

O’Donnell MR. Acute leukemias. In: Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ, eds. Cancer Management: A Multidisciplinary Approach. 13th ed. Lawrence, KS: UBM Medica; 2010:821-850.

Pui CH, Robison LL, Look AT. Acute lymphoblastic leukemia. Lancet. 2008;371:1030-1043.

Rowe JM, Buck G, Burnett AK, et al. Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993. Blood. 2005:106;3760-3767.

Topp MS, Kufer P, Gokbuget N, et al. Targeted therapy with the T-cell-engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic leukemia patients results in high response rate and prolonged leukemia-free survival. J Clin Oncol. 2011;29:2493-2498.

Zeidan AM, Ricklis RM, Carraway HE, et al. Phase 1 dose-escalation trial of clofarabine followed by escalating dose of fractionated cyclophosphamide in adults with relapsed or refractory acute leukaemias. Br J Haematol. 2012;158(2):198-207. Epub 2012 May 18.

Nuestra labor es posible gracias a generosos donantes como usted.

Done ahora para que podamos continuar brindando acceso a información crítica sobre el cáncer, recursos y apoyo y así mejorar las vidas de las personas con cáncer y sus familias.